$CASC Cascadian Therapeutics, Inc. Insider Trading
Get free email notifications about insider trading in Cascadian Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Cascadian Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Cascadian Therapeutics, Inc. for free.
CIK Number: 0001412067
IRS Number: 260868560
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Trading Symbol: CASC
Company Address: 3101 WESTERN AVE. SUITE 600 SEATTLE 98121
Phone number: (206) 801-2100
Former name: Biomira CORP, date of change: 2007-09-11
Former name: Oncothyreon Inc., date of change: 2007-09-27
Prev close: $1.21
Average Daily Volume: 1,002,310
Days Low: $0.00
Year Low: $0.90
Year High: $4.11
Cascadian Therapeutics, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 13 2018 | CASC | Cascadian Therapeu ... | Walker Luke Nathaniel | SVP, Clinical Devel ... | Option Exercise | D | 0.00 | 130,000 | 0 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Walker Luke Nathaniel | SVP, Clinical Devel ... | Option Exercise | D | 0.00 | 12,000 | 0 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Walker Luke Nathaniel | SVP, Clinical Devel ... | Option Exercise | D | 0.00 | 7,800 | 0 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Walker Luke Nathaniel | SVP, Clinical Devel ... | Option Exercise | D | 3.99 | 50,000 | 199,500 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Walker Luke Nathaniel | SVP, Clinical Devel ... | Option Exercise | D | 4.64 | 35,100 | 162,864 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Walker Luke Nathaniel | SVP, Clinical Devel ... | Option Exercise | D | 6.90 | 20,834 | 143,755 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Walker Luke Nathaniel | SVP, Clinical Devel ... | Option Exercise | D | 6.90 | 8,334 | 57,505 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Walker Luke Nathaniel | SVP, Clinical Devel ... | Option Exercise | D | 21.06 | 5,834 | 122,864 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Walker Luke Nathaniel | SVP, Clinical Devel ... | Option Exercise | D | 10.56 | 1,250 | 13,200 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Walker Luke Nathaniel | SVP, Clinical Devel ... | Option Exercise | D | 10.44 | 2,500 | 26,100 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Walker Luke Nathaniel | SVP, Clinical Devel ... | Option Exercise | D | 28.44 | 1,250 | 35,550 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Walker Luke Nathaniel | SVP, Clinical Devel ... | Option Exercise | D | 41.52 | 334 | 13,868 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Walker Luke Nathaniel | SVP, Clinical Devel ... | Option Exercise | D | 35.88 | 2,500 | 89,700 | 0 | |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Walker Luke Nathaniel | SVP, Clinical Devel ... | Sell | U | 0.00 | 10,315 | 0 | 0 | 10.3 K to 0 (-100.00 %) |
Mar 13 2018 | CASC | Cascadian Therapeu ... | James Steven P | Director | Option Exercise | D | 0.00 | 13,927 | 0 | 0 |